Cui X, Li Y, Zhang C, Qi Y, Sun Y, Li W
Front Microbiol. 2024; 14:1294146.
PMID: 38169727
PMC: 10758443.
DOI: 10.3389/fmicb.2023.1294146.
Tian R, Huang Z, Li L, Yuan J, Zhang Q, Meng L
Nucleic Acids Res. 2023; 51(9):4237-4251.
PMID: 36864748
PMC: 10201430.
DOI: 10.1093/nar/gkad105.
Senapati R, Senapati N, Dwibedi B
Infect Agent Cancer. 2016; 11:59.
PMID: 27933097
PMC: 5123406.
DOI: 10.1186/s13027-016-0107-4.
Li W, Wang W, Si M, Han L, Gao Q, Luo A
J Cancer Res Clin Oncol. 2008; 134(12):1355-61.
PMID: 18478264
DOI: 10.1007/s00432-008-0413-3.
Bechtold V, Beard P, Raj K
J Virol. 2003; 77(3):2021-8.
PMID: 12525636
PMC: 140940.
DOI: 10.1128/jvi.77.3.2021-2028.2003.
Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses.
Tan S, Bartsch D, Schwarz E, Bernard H
J Virol. 1998; 72(5):3610-22.
PMID: 9557642
PMC: 109582.
DOI: 10.1128/JVI.72.5.3610-3622.1998.
The carboxyl-terminal region of the human papillomavirus type 16 E1 protein determines E2 protein specificity during DNA replication.
Zou N, Liu J, Kuo S, Broker T, Chow L
J Virol. 1998; 72(4):3436-41.
PMID: 9525677
PMC: 109845.
DOI: 10.1128/JVI.72.4.3436-3441.1998.
Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix.
Pirami L, Giache V, Becciolini A
J Clin Pathol. 1997; 50(7):600-4.
PMID: 9306943
PMC: 500071.
DOI: 10.1136/jcp.50.7.600.
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.
Yamada T, Manos M, Peto J, Greer C, Munoz N, Bosch F
J Virol. 1997; 71(3):2463-72.
PMID: 9032384
PMC: 191357.
DOI: 10.1128/JVI.71.3.2463-2472.1997.
Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.
Wheeler C, Yamada T, Hildesheim A, Jenison S
J Clin Microbiol. 1997; 35(1):11-9.
PMID: 8968874
PMC: 229505.
DOI: 10.1128/jcm.35.1.11-19.1997.
Use of multiple PCR primer sets for optimal detection of human papillomavirus.
Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R
J Clin Microbiol. 1996; 34(9):2095-100.
PMID: 8862564
PMC: 229196.
DOI: 10.1128/jcm.34.9.2095-2100.1996.
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
May M, Dong X, Stubenrauch F, Fuchs P, Pfister H
EMBO J. 1994; 13(6):1460-6.
PMID: 8137827
PMC: 394965.
DOI: 10.1002/j.1460-2075.1994.tb06400.x.
Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias.
Fujinaga Y, Okazawa K, Nishikawa A, Yamakawa Y, Fukushima M, Kato I
Virus Genes. 1994; 9(1):85-92.
PMID: 7871765
DOI: 10.1007/BF01703438.
The HPV 16 genome induces carcinomas and T-cell lymphomas in transgenic mice.
Yang J, Liu C, Iannaccone P
Am J Pathol. 1995; 147(1):68-78.
PMID: 7604886
PMC: 1869873.
Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumors.
Schneider-Maunoury S, CROISSANT O, Orth G
J Virol. 1987; 61(10):3295-8.
PMID: 3041049
PMC: 255912.
DOI: 10.1128/JVI.61.10.3295-3298.1987.
The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein.
Smotkin D, WETTSTEIN F
J Virol. 1987; 61(5):1686-9.
PMID: 3033296
PMC: 254156.
DOI: 10.1128/JVI.61.5.1686-1689.1987.
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.
Phelps W, Howley P
J Virol. 1987; 61(5):1630-8.
PMID: 3033289
PMC: 254145.
DOI: 10.1128/JVI.61.5.1630-1638.1987.
Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines.
Baker C, Phelps W, Lindgren V, Braun M, Gonda M, Howley P
J Virol. 1987; 61(4):962-71.
PMID: 3029430
PMC: 254051.
DOI: 10.1128/JVI.61.4.962-971.1987.
Induction of anchorage-independent growth of human embryonic fibroblasts with a deletion in the short arm of chromosome 11 by human papillomavirus type 16 DNA.
Smits H, Raadsheer E, Rood I, Mehendale S, Slater R, van der Noordaa J
J Virol. 1988; 62(12):4538-43.
PMID: 2846869
PMC: 253564.
DOI: 10.1128/JVI.62.12.4538-4543.1988.
A viral-cellular junction fragment from a human papillomavirus type 16-positive tumor is competent in transformation of NIH 3T3 cells.
Le J, Defendi V
J Virol. 1988; 62(11):4420-6.
PMID: 2845153
PMC: 253887.
DOI: 10.1128/JVI.62.11.4420-4426.1988.